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Abstract
Paraoxonase 1 (PON1) is a HDL-associated esterase/lactonase and its activity is inversely related to the risk of
cardiovascular diseases. The aim of the present study was to evaluate the effect of a high-salt diet on serum PON1
activity in fructose-fed insulin-resistant rats. Adult male Fischer rats were initially divided into two groups. Control
(CON), which received a normal salt diet and drinking water throughout the study; high fructose (HF), which
received a normal salt diet and 20% fructose supplemented drinking water. After 10 weeks, half of the animals from
HF group were randomly switched to a high-salt diet and 20% fructose supplemented drinking water (HFS) for
more 10 weeks. Serum PON1 activity was determined by synthetic substrate phenyl acetate. HFS rats showed
markedly decreased PON1 activity (HFS rats, 44.3 ± 14.4 g/dL versus CON rats, 64.4 ± 13.3 g/dL, P< 0.05) as
compared to controls. In parallel, the level of oxidative stress, as indicated by thiobarbituric acid reactive substances
(TBARS), was increased in HFS rats by 1.2-fold in the liver in relation to controls and was negatively correlated with
PON activity. Differential leukocyte counts in blood showed a significant change in lymphocytes and monocytes
profile. In conclusion, these results show that PON1 activity is decreased in fructose-fed insulin-resistant rats on a
high-salt diet, which may be associated with increased oxidative stress, leading to inflammation.
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Findings
Diabetes is a long-term disorder affecting the inner walls
of arteries and is characterized by endothelial dysfunc-
tion and oxidative modification of low density lipopro-
tein (LDL) which may induce atherosclerosis [1]. In
contrast, it is supposed that LDL particles can be pro-
tected from free radical-induced oxidation by an HDL
linked enzyme, paraoxonase 1 (PON1).
Although the precise mechanism of PON1 effect is
not yet completely known, it may possess anti-
atherogenic and anti-inflammatory properties, resulting
from its ability to destroy modified phospholipids and to
prevent accumulation of oxidized lipids in lipoproteins
[2-5]. In diabetes experimental models, it has been
reported that PON1 enzymatic activity is decreased [6,7]
and reduced PON1 activity was suggested to play a role
in the severity of coronary atherosclerosis [2]. Nonethe-
less, oxidative stress pathways have also been proposed
to act in this process, with increased reactive oxygen
species (ROS) production and/or impaired antioxidant
defense, which may in turn lead to excessive peroxida-
tion of polyunsaturated fatty acids contained in LDL
particles.
Our laboratory has recently reported that a hypercho-
lesterolemic diet in rats cause a significant reduction of
PON1 activity, associated with increased oxidative stress
[8]. Once rats fed a high dose of fructose are considered
a nutritional model for insulin resistance [9-11], the
present study investigated the effects of a high-salt diet
in fructose-fed insulin-resistant rats on PON1 and its in-
fluence in serum and oxidative parameters. In addition
the influence of the diets on the inflammatory cells pro-
file was also assessed.
Twenty-nine Fisher male rats, weighing about 300 g,
obtained from the School of Nutrition of the Federal
University of Ouro Preto, were housed in a temperature
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and humidity controlled room with a 12:12-h light/dark
cycle (lights on at 06.00 AM). Animals were initially
divided into two groups. The control group (CON)
received the standard AIN93 diet [12] and the high
fructose-fed group (HF) was given supplemented fruc-
tose as a 20% solution instead of pure water ad libitum
to induce insulin resistance. After 10 weeks, HF animals
were divided into 2 groups: those that continued to re-
ceive only 20% fructose in water and those switched to
the high fructose regimen+ 8% NaCl in the standard
AIN93 diet (HFS). After 20 weeks fasting rats were
anesthetized and sacrificed. The experiments were
approved by the institutional Ethics Committee with
protocol number 068/2011 and were performed in ac-
cordance with the principles of the Brazilian College of
Animal Experimentation [13].
To determine the levels of serum components, blood
samples were collected in test tubes and centrifuged.
Serum total protein, albumin, total cholesterol, HDL-
cholesterol and triglyceride were assayed with colorimet-
ric or enzymatic methods using commercially available
kits Labtest (Lagoa Santa, MG, Brazil) # 99, 19, 76, 13
and 87, respectively. The atherogenic index was calcu-
lated as follows: total cholesterol - HDL cholesterol/
HDL cholesterol.
PON activity was measured by a spectrophotometric
assay using phenyl acetate as substrate as described by
Beltowski et al. [14]. The enzymatic activity was calcu-
lated assuming the molar extinction coefficient of phe-
nylacetate to be 1310 L . mol-1 . cm-1. The results were
expressed in units per milliliter, where 1 U of arylester-
ase hydrolyzes 1 mmol of phenylacetate per minute.
Basal lipid peroxidation status was measured in the liver
by TBARS assay [15].
A drop of blood was used to prepare blood smears,
which were stained with Panotic Fast which use essential
components dyes of Romanowsky [16]. Counts of 100
leukocytes were performed and the results were
expressed as subtypes identified in polymorphonuclear
(PMN), lymphocyte or monocyte cells.
The normality of the sample distribution for each con-
tinuous parameter was tested with the Kolmogorov-
Smirnov test. The significance of any differences in pro-
portions or medians was tested with Kruskal-Wallis test,
and in means analysis of variance (ANOVA) was used,
followed by Dunns and Tukey test, respectively. Pear-
son’s correlation coefficients were used to test the cor-
relation among variables. A p-value of less than 0.05 was
considered statistically significant.
A high-salt diet in fructose-fed insulin-resistant rats
significantly decreased serum levels of total protein, al-
bumin, total cholesterol and HDL-cholesterol after 20
wk of treatment in relation the control group as demon-
strated in Table 1. Fructose-fed rats showed significantly
higher triglyceride concentrations in both HF and HFS
groups (P< 0.05) as compared to control rats. The
atherogenic index of each experimental group was also
calculated and increased 66% in HFS rats as compared
to controls. PON1 activity markedly fell to 68% in those
animals, as compared to control and HF rats (P< 0.05
and P< 0.01, respectively) (Table 1).
Increased oxidative stress was noted in the liver
obtained fromHFS rats, sinceTBARS levels were raised by
1.2 times (P< 0.05) as compared to controls (Figure 1A).
When data from all experimental groups were analyzed
together, the effects of all treatments on serum PON1
activity were positively correlated with total protein
(r = 0.7728, P< 0.001) (Figure 1B), albumin (r = 0.8142,
P< 0.001) (Figure 1C), total cholesterol (r = 0.6228, P
< 0.001) (Figure 1D) and HDL-cholesterol (r = 0.6145,
P< 0.001) (Figure 1E). In addition, a negative correl-
ation was found between serum PON1 activity and
liver TBARS levels (r =− 0.6262, P< 0.01) (Figure 1F).
Differential leukocyte counts in the total blood smear
in insulin-resistant rats treated or not with the high-salt
diet showed a significant decrease in the lymphocyte
profile in relation to the control group, but the percent-
age of polymorphonuclear cells (PMNs) remained un-
changed. Salt treatment caused a significant increase in
the monocyte profile in HF and HFS rats as compared
to the CON rats (Table 2).
In this study we observed a decrease in serum PON1
activity in insulin-resistant rats on a high-salt diet and
an association among PON1, oxidative stress and in-
flammation, which can occur during the development of
atherosclerosis.
HDL is the most powerful independent negative pre-
dictor of cardiovascular events. The protective effects of
Table 1 Serum total protein, albumin, triglyceride, total
cholesterol, HDL-cholesterol, atherogenic index and
PON1 activity of experimental rats after 20 weeks of
treatment
CON HF HFS
Number of rats/group 9 10 10
Total protein (g/dL) 7,0 ± 2,0a 6,3 ± 1,8a 4,9 ± 1,5b
Albumin (g/dL) 2,8 ± 0,2a 2,6 ± 0,3a 2,1 ± 0,2b
Triglyceride (mg/dL) 126,1 ± 30,8b 183,5 ± 58,7a 197,1 ± 55,9a
Total cholesterol (mg/dL) 97,9 ± 20,9a 98,0 ± 13,3a 69,3 ± 9,0b
HDL-cholesterol (mg/dL) 66,4 ± 10,6a 65,8 ± 9,4a 43,6 ± 12,17b
Atherogenic index 0,39 ± 0,12b 0,47 ± 0,11b 0,65 ± 0,26a
PON1 (g/dL) 64,45 ± 13,36a 65,44 ± 17,29a 44,3 ± 14,43b
Values (mean ± SD) were obtained from groups CON (AIN diet and water for
20 weeks); HF (AIN diet + 20% fructose solution in water for 20 weeks) and
HFS (8% NaCl in AIN93 diet + 20% fructose solution in water for 10 weeks after
previous treatment for a period of 10 weeks with HF). Different superscript
letters within the same row indicate significant difference at P< 0.05 by
one-way ANOVA followed by Tukey’s test. High-density lipoprotein (HDL);
paraoxonase1 activity (PON1).
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HDL have been first attributed to its capacity to pro-
mote cellular cholesterol efflux from peripheral cells and
deliver it to the liver for excretion, a process known as
reverse cholesterol transport [1]. Furthermore HDL has
also attracted particular attention because of its antioxi-
dative potential. Interestingly this work sustains the rela-
tionship between low paraoxonase activity and diseases
with low antioxidant defense and excessive lipid peroxi-
dation since paraoxonase may act protectively in athero-
genesis by hydrolyzing some products of lipid
peroxidation and consequently by limiting LDL oxida-
tion and foam cell formation [17].
In our model, serum albumin and protein levels are
reduced probably due to protein synthesis disruption in
the liver as observed by Shinn and Moon [18]. The
damaged hepatocytes are potent sources of reactive oxy-
gen intermediates and oxidative stress is important in
many types of liver injury. Lipid peroxidation, which was
found increased in this study, could change the proper-
ties of biological membranes, resulting in severe cell
damage and play a significant role in the mechanisms
related to the alterations observed by us, as it has been
previously documented [19].
In rats, unlike in humans and rabbits, plasma triglycer-
ides and cholesterol are transported predominantly by
HDL [14] and fructose per se, after having reached the
liver, may contribute to the increase in serum triglycer-
ide as demonstrated in this study and by others authors
[9,20,21]. We showed that low PON1 activity is asso-
ciated with decreased HDL levels and this contributes to
the hypothesis that PON1 is involved in the preservation
of HDL. Since PON1 exerts a protective effect against
oxidative stress, it is logical to find an association be-
tween this enzyme and liver impairment. PON1 activity
decreased while lipid peroxidation increased in HFS rats,
suggesting that PON1 activity may be involved in the
defense against free radical production in liver orga-
nelles. Moreover, the atherogenic index of these animals
indicated them to be more susceptible to the develop-
ment of atherosclerosis. However the results of this
study showed that PON1 activity towards synthetic
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Figure 1 (A) Liver TBARS levels; scatter plots illustrating the association between (B) PON1 and total protein and (C) albumin and (D)
Total cholesterol and (E) HDL-cholesterol and (F) TBARS in experimental groups. Control (dark filled circle); high-fructose (dark filled triangle)
and high-fructose + salt (dark filled square) rats. High-density lipoprotein (HDL); paraoxonase1 activity (PON1).
Table 2 Polymorphonuclear cells, lymphocytes and
monocytes count of experimental rats after 20 weeks of
treatment
CON HF HFS
PMN cells (%) 5-15 3-27 7-23
Lymphocytes (%) 19-58 4-33** 7-20***
Monocytes (%) 27-76 36-85** 40-83*
Values were obtained from groups CON (AIN diet and water for 20 weeks); HF
(AIN diet + 20% fructose solution in water for 20 weeks), and HFS (8% high salt
in AIN93 diet + 20% fructose solution in water for 10 weeks after previous
treatment for a period of 10 weeks with HF). Kruskall Wallis test followed by
Dunns test. Values indicate lowest and highest percentage of cells counted
respectively. *P< 0.05; **P< 0.01; ***P< 0.001. Polymorphonuclear (PMN) cells.
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substrates reflects its relationship to oxidative stress by
means of the marker used but this hypothesis needs sup-
port by means of further investigation.
A previous study has shown that PON1 protects
against atherosclerosis, by its ability to reduce macro-
phage foam cell formation, via reducing oxidative stress
and stimulation of cholesterol efflux from macrophages
[22]. The present study proposes that oxidatively modi-
fied LDL impair endothelial function, stimulate inflam-
matory response of monocytes/macrophages, activate
migration and proliferation of vascular smooth muscle
cells and induce immune response, as indicated by the
increase of monocytes in HF and HFS groups. Therefore,
inactivation of PON1 in HFS rats could reduce the
ability of HDL to inhibit LDL modification and also
decrease the ability of HDL to inhibit monocytic-
endothelial interactions. Both conditions appear to be
important in the inflammatory response in arterial wall
cells, as demonstrated by the change in lymphocyte
profile in relation to the control group, since this is a
common finding during the systemic inflammatory re-
sponse. In addition, clinical and animal studies suggest
that low lymphocyte count plays a putative role in
chronic inflammation [23].
Our dietetic model was chosen due its relevance to
human nutrition because it mimics a common Western
diet, with high consumption of sugar drinks and salty
foods and this study is the first one to show an associ-
ation between paraoxonase status and salt overload in
insulin-resistant rats. This supports the relationship be-
tween low PON1 activity and diseases with low antioxi-
dant defense and excessive lipid peroxidation.
Paraoxonase may perform protectively in atherogenesis
by hydrolyzing some products of lipid peroxidation and
consequently by limiting LDL oxidation and foam cell
formation [24]. This allows us to hypothesize that para-
oxonase activity may lead to failure in the protection of
LDL oxidation in insulin-resistant subjects on a high-salt
diet. Thus the lack of prevention of LDL oxidation by
HDL could be explained by the quantitative alteration of
HDL, since PON1 generally seems to contribute to the
antioxidant properties of HDL.
In conclusion, the present study indicates that a high-
salt diet in fructose-fed rats leads to lowered serum
PON1 activity, with deleterious effects on the antioxi-
dant defense system. Furthermore, we suggest that a
change in blood cells profile would reflect the oxidative
stress detected. These findings we believe to be relevant
in the field of human nutrition.
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